Orally Active Osteoanabolic Agent GTDF Binds to Adiponectin Receptors, With a Preference for AdipoR1, Induces Adiponectin-Associated Signaling, and Improves Metabolic Health in a Rodent Model of Diabetes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Orally Active Osteoanabolic Agent GTDF Binds to Adiponectin Receptors, With a Preference for AdipoR1, Induces Adiponectin-Associated Signaling, and Improves Metabolic Health in a Rodent Model of Diabetes
Authors
Keywords
-
Journal
DIABETES
Volume 63, Issue 10, Pages 3530-3544
Publisher
American Diabetes Association
Online
2014-05-22
DOI
10.2337/db13-1619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RNA-Binding Protein PTB and MicroRNA-221 Coregulate AdipoR1 Translation and Adiponectin Signaling
- (2013) Y. Lustig et al. DIABETES
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- Identification of Adiponectin Receptor Agonist Utilizing a Fluorescence Polarization Based High Throughput Assay
- (2013) Yiyi Sun et al. PLoS One
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice
- (2012) Soo-Mi Jeong et al. Nutrition Research and Practice
- 125I-Labeled Quercetin as a Novel DNA-Targeted Radiotracer
- (2011) Seyed Jalal Hosseinimehr et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
- (2011) F. Karpe et al. DIABETES
- Differential Expression of Novel Adiponectin Receptor-1 Transcripts in Skeletal Muscle of Subjects With Normal Glucose Tolerance and Type 2 Diabetes
- (2011) Reut Ashwal et al. DIABETES
- A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: The role of aryl hydrocarbon receptor as a mediator of osteogenic action
- (2011) Kunal Sharan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bile Acid Receptor Agonist GW4064 Regulates PPARγ Coactivator-1α Expression Through Estrogen Receptor-Related Receptor α
- (2011) Shailendra Kumar Dhar Dwivedi et al. MOLECULAR ENDOCRINOLOGY
- A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone
- (2011) J. A. Siddiqui et al. OSTEOPOROSIS INTERNATIONAL
- Early Hepatic Insulin Resistance Precedes the Onset of Diabetes in Obese C57BLKS-db/db Mice
- (2010) R. C. Davis et al. DIABETES
- The Glutamate Agonist Homocysteine Sulfinic Acid Stimulates Glucose Uptake through the Calcium-dependent AMPK-p38 MAPK-Protein Kinase C ζ Pathway in Skeletal Muscle Cells
- (2010) Ji Hae Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adiponectin-induced ERK and Akt Phosphorylation Protects against Pancreatic Beta Cell Apoptosis and Increases Insulin Gene Expression and Secretion
- (2010) Nadeeja Wijesekara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quercetin's Influence on Exercise Performance and Muscle Mitochondrial Biogenesis
- (2010) DAVID C. NIEMAN et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1
- (2010) Masato Iwabu et al. NATURE
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
- (2010) William L Holland et al. NATURE MEDICINE
- Adiponectin Levels and Risk of Type 2 Diabetes
- (2009) Shanshan Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Initiation of myoblast to brown fat switch by a PRDM16–C/EBP-β transcriptional complex
- (2009) Shingo Kajimura et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started